JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,855,000 | -60.4% | 82,988 | -77.4% | 0.14% | -71.8% |
| Q4 2017 | $4,682,000 | -16.5% | 367,223 | +2.1% | 0.49% | -50.5% |
| Q3 2017 | $5,605,000 | +11.1% | 359,738 | 0.0% | 0.99% | +18.3% |
| Q2 2017 | $5,047,000 | -47.2% | 359,738 | -17.3% | 0.84% | -39.7% |
| Q1 2017 | $9,565,000 | – | 434,976 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |